Quick Answer
Organon & Co. reported Shares Outstanding of 260.32 million shares for fiscal year 2025.
Organon & Co. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 260.32M | +1.0% |
| 2024 | 257.80M | +0.9% |
| 2023 | 255.63M | +0.5% |
| 2022 | 254.37M | +0.3% |
| 2021 | 253.55M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 259.98M | +0.9% | +0.0% |
| June 30, 2025 | 259.96M | +1.0% | +0.8% |
| March 31, 2025 | 257.95M | +0.8% | +0.1% |
| December 31, 2024 | 257.80M | +0.9% | +0.1% |
| September 30, 2024 | 257.54M | +0.8% | +0.0% |
| June 30, 2024 | 257.47M | +0.7% | +0.6% |
| March 31, 2024 | 255.85M | +0.6% | +0.1% |
| December 31, 2023 | 255.63M | +0.5% | +0.0% |
- Organon & Co. showed an increase of +1.0% in Shares Outstanding compared to the prior fiscal year.
- Over the 2021–2025 period, Organon & Co.’s shares outstanding has grown by 2.7% (from 253.55 million shares to 260.32 million shares).
- The most recent figure is from Organon & Co.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: